These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17068789)

  • 41. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways.
    Cookson MR
    Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009415. PubMed ID: 22951446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
    Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
    Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.
    Nuytemans K; Theuns J; Cruts M; Van Broeckhoven C
    Hum Mutat; 2010 Jul; 31(7):763-80. PubMed ID: 20506312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.
    Venderova K; Kabbach G; Abdel-Messih E; Zhang Y; Parks RJ; Imai Y; Gehrke S; Ngsee J; Lavoie MJ; Slack RS; Rao Y; Zhang Z; Lu B; Haque ME; Park DS
    Hum Mol Genet; 2009 Nov; 18(22):4390-404. PubMed ID: 19692353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Animal models of Parkinson's disease: vertebrate genetics.
    Lee Y; Dawson VL; Dawson TM
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 22960626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular biology for familial Parkinson's disease].
    Shiba K; Hattori N
    Nihon Rinsho; 2004 Sep; 62(9):1617-22. PubMed ID: 15462374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RNA metabolism in the pathogenesis of Parkinson׳s disease.
    Lu B; Gehrke S; Wu Z
    Brain Res; 2014 Oct; 1584():105-15. PubMed ID: 24631951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic factors involved in the pathogenesis of Parkinson's disease.
    Lee FJ; Liu F
    Brain Res Rev; 2008 Aug; 58(2):354-64. PubMed ID: 18313759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.
    Nuytemans K; Meeus B; Crosiers D; Brouwers N; Goossens D; Engelborghs S; Pals P; Pickut B; Van den Broeck M; Corsmit E; Cras P; De Deyn PP; Del-Favero J; Van Broeckhoven C; Theuns J
    Hum Mutat; 2009 Jul; 30(7):1054-61. PubMed ID: 19405094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
    George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
    J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Development in researches for familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2009 Nov; 49(11):882-4. PubMed ID: 20030237
    [No Abstract]   [Full Text] [Related]  

  • 56. Modeling neurodegeneration in zebrafish.
    Xi Y; Noble S; Ekker M
    Curr Neurol Neurosci Rep; 2011 Jun; 11(3):274-82. PubMed ID: 21271309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of DJ-1 in Parkinson's disease.
    Lev N; Roncevic D; Ickowicz D; Melamed E; Offen D
    J Mol Neurosci; 2006; 29(3):215-25. PubMed ID: 17085780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Frontier researches for the development of molecular-targeted therapies for familial Parkinson disease].
    Imai Y; Takahashi R
    Brain Nerve; 2009 Aug; 61(8):903-13. PubMed ID: 19697879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The genetics of Parkinson's syndromes: a critical review.
    Hardy J; Lewis P; Revesz T; Lees A; Paisan-Ruiz C
    Curr Opin Genet Dev; 2009 Jun; 19(3):254-65. PubMed ID: 19419854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.